Lynn L. Silver

Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis

Evelina Tacconelli, Elena Carrara, Alessia Savoldi et al. · The Lancet Infectious Diseases · 2017 · 5.8K citations

Bacterial Resistance, Antimicrobial Drug Discovery, Antimicrobial Susceptibility +14

Platensimycin is a selective FabF inhibitor with potent antibiotic properties

Jun Wang, S.M. Soisson, Katherine Young et al. · Nature · 2006 · 809 citations

Antibiotics, Medicine, Pharmacotherapy +11

Outbreak of <i>Klebsiella pneumoniae</i> Producing a New Carbapenem-Hydrolyzing Class A β-Lactamase, KPC-3, in a New York Medical Center

Neil Woodford, Philip M. Tierno, Katherine Young et al. · Antimicrobial Agents and Chemotherapy · 2004 · 442 citations · Full text

Medical Microbiology, Antimicrobial Resistance Gene, Antimicrobial Susceptibility +15

Antibacterial Agents That Inhibit Lipid A Biosynthesis

Hiroshi Ōnishi, Barbara A. Pelak, Lynn S. Gerckens et al. · Science · 1996 · 409 citations

Antibacterial Agents, Biosynthesis, Antimicrobial Susceptibility +12

Vancomycin Derivatives That Inhibit Peptidoglycan Biosynthesis Without Binding <scp>d</scp> -Ala- <scp>d</scp> -Ala

Min Ge, Zhong Chen, Harold Russell et al. · Science · 1999 · 319 citations

Glycobiology, Antimicrobial Chemotherapy, Pharmaceutical Chemistry +19